Novozymes A-S (B) Aktie
52,26
EUR
+1,14
EUR
+2,23
%
47,68
CHF
+1,08
CHF
+2,32
%
Werbung
Novozymes A-S (B) Aktie Analyse
| 03.09.12 | Novozymes A-S (B) buy | ING | |
| 28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley |
Werbung
Werbung